Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03027063 · ClinicalTrials.gov registry record · NA
Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03027063: Completed NA study, sponsored by Johns Hopkins University.
NCT03027063 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03027063, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This research is being done to determine whether exercise while receiving doxorubicin or Adriamycin chemotherapy for breast cancer can reduce the cardio-toxic effects of this treatment on the heart and improve other outcomes related to cancer such as tumor markers, nausea, fatigue and the ability to tolerate chemotherapy.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL 10,000 steps
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03027063
The ClinicalTrials.gov registry entry for NCT03027063 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03027063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03027063 about?
NCT03027063 is a clinical study titled "Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.". This research is being done to determine whether exercise while receiving doxorubicin or Adriamycin chemotherapy for breast cancer can reduce the cardio-toxic effects of this treatment on the heart and improve other outcomes related to cancer such as tumor markers, nausea, fatigue and the ability to...
What is the current status of trial NCT03027063?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-01. Estimated completion is 2019-10.
What interventions are being tested in trial NCT03027063?
The interventions under investigation include: Usual Care (BEHAVIORAL), 10,000 steps (BEHAVIORAL).
Who is sponsoring clinical trial NCT03027063?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.